Clinical Trials
23 trialsMulticenter Prospective Study on MRI AI Model for Midline Glioma Subtyping and Prognosis:
Xiangya Hospital of Central South University
Rare CNS Tumors Outcomes &Risk
National Institutes of Health Clinical Center (CC)
Multimodal Machine Learning Characterization of Solid Tumors
Massachusetts General Hospital
CSF-IMR
Medical University of Warsaw
[18F]FET PET for Characterization of Progressive or Recurrent Glioma From Treatment Related Changes
Telix Pharmaceuticals (Innovations) Pty Limited
Cognitive Changes of IDH-mutant and IDH-wildtype Glioma Patients After Chemoradiotherapy With Radiation Dose to the Resting State Networks
Washington University School of Medicine
BRAIN MATRIX
University of Birmingham
ResPGlioma
Universita degli Studi di Genova
Adaptive Radiotherapy and MRIs Based on Patients With Newly Diagnosed High-Grade Glioma
Columbia University
LGG PRO's
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption in GBM Patients
InSightec
APT-HGG
IRCCS Ospedale San Raffaele
A Pilot Study Using 18F-DOPA PET-guided Radiotherapy in Gliomas
Mayo Clinic
Targeted Pediatric High-Grade Glioma Therapy
Nationwide Children's Hospital
UFGAG
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
Natural History of and Specimen Banking for People With Tumors of the Central Nervous System
National Institutes of Health Clinical Center (CC)
Clinical, patHOlogical and Imaging Project of nEuro-oncology (HOPE)
Beijing Tiantan Hospital
m-ctDNA
University Health Network, Toronto
SC-Het-GM-CCS
The Children's Hospital of Zhejiang University School of Medicine
Serial Advanced Magnetic Resonance Imaging Scan for Guidance of Personalized Adaptive Radiotherapy for High Grade Glioma
M.D. Anderson Cancer Center
Improve TMZ
University College Cork
GLIOTARG
Blokhin's Russian Cancer Research Center
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
M.D. Anderson Cancer Center